Spark Therapeutics signs gene therapy deal with French nonprofit – Philadelphia Business Journal
Philadelphia Business Journal |
Spark Therapeutics signs gene therapy deal with French nonprofit
Philadelphia Business Journal Spark Therapeutics said Wednesday it has entered into a licensing agreement with Genethon for the development and commercialization of an adeno-associated viral gene therapy targeting the liver to address a rare genetic disease. Genethon, based in … |
